ERBB2 and breast carcinoma: Breast cancers are categorized into three main groups based on cellular markers reflecting available targeted therapies: Estrogen receptor (ER) or progesterone receptor (PR) positive, Her2 positive and triple negative breast cancer with no ER, PR and Her2 expression having no standard treatment option and the poorest survival3.